Physiological roles of MKK4 and MKK7: Insights from animal models

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1773, Issue 8, 2007, Pages 1349-1357

  Wang, Xin ^a   Destrument, Auriane ^a   Tournier, Cathy ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

JNK; JNKK; MAPK; MKK4; MKK7; SEK1; Stress

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; MITOGEN ACTIVATED PROTEIN KINASE KINASE 7; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE;

CELLULAR DISTRIBUTION; GENE DELETION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; STRESS;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; CLONING, MOLECULAR; FEMALE; HEART DISEASES; IMMUNE SYSTEM; LIVER; MAP KINASE KINASE 4; MAP KINASE KINASE 7; MICE; MICE, KNOCKOUT; MODELS, ANIMAL; MOLECULAR SEQUENCE DATA; NEOPLASMS; NEURONS; PREGNANCY; TISSUE DISTRIBUTION;

ANIMALIA; MUS;

EID: 34547233770     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2006.10.016     Document Type: Review

References (80)

1. Davis R.J. Signal transduction by the JNK group of MAP kinases. Cell 103 (2000) 239-252
2. Yang D.D., Kuan C.Y., Whitmarsh A.J., Rincon M., Zheng T.S., Davis R.J., Rakic P., and Flavell R.A. Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature 389 (1997) 865-870
3. Kuan C.Y., Yang D.D., Roy D.R.S., Davis R.J., Rakic P., and Flavell R.A. The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development. Neuron 22 (1999) 667-676
4. Widmann C., Gibson S., Jarpe M.B., and Johnson G.L. Mitogen-activated protein kinase: conservation of a three-kinase module form yeast to human. Physiol. Rev. 79 (1999) 143-180
5. Zarubin T., and Han J. Activation and signaling of the p38 MAP kinase pathway. Cell Res. 15 (2005) 11-18
6. Tanoue T., and Nishida E. Molecular recognitions in the MAP kinase cascades. Cell. Signal. 15 (2003) 455-462
7. Whitmarsh A.J., and Davis R.J. Structural organization of MAP-kinase signaling modules by scaffold proteins in yeast and mammals. Trends Biochem. Sci. 12 (1998) 481-485
8. Yang S., Sharrocks A.D., and Whitmarsh A.J. Transcriptional regulation by the MAP kinase signaling cascades. Gene 320 (2003) 3-21
9. Chang L., Jones Y., Ellisman M.H., Goldstein L.S.B., and Karin M. JNK1 is required for maintenance of neuronal microtubules and controls phosphorylation of microtubule-associated proteins. Dev. Cell 4 (2003) 521-533
10. Björkblom B., Östman N., Hongisto V., Komarovski V., Filén J.-J., Nyman T.A., Kallunki T., Courtney M.J., and Coffey E.T. Constitutively active cytoplasmic c-Jun N-terminal kinase 1 is a dominant regulator of dendritic architecture: role of microtubule-associated protein 2 as an effector. J. Neurosci. 25 (2005) 6350-6361
11. Tournier C., Hess P., Yang D.D., Xu J., Turner T.K., Nimnual A., Bar-Sagi D., Jones S.N., Flavell R.A., and Davis R.J. Requirement of JNK for stress-induced activation of the cytochrome c- mediated death pathway. Science 288 (2000) 870-874
12. Lei K., Nimnual A., Zong W.X., Kennedy N.J., Flavell R.A., Thompson C.B., Bar-Sagi D., and Davis R.J. The Bax subfamily of Bcl2-related proteins is essential for apoptotic signal transduction by c-Jun NH(2)-terminal kinase. Mol. Cell. Biol. 22 (2002) 4929-4942
13. Deng Y., Ren X., Yang L., Lin Y., and Wu X. A JNK-dependent pathway is required for TNFα-induced apoptosis. Cell 115 (2003) 61-70
14. Lei K., and Davis R.J. JNK phosphorylation of Bim-related members of the Bcl2 family induces Bax-dependent apoptosis. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 2432-2437
15. Putcha G.V., Le S., Frank S., Besirli C.G., Clark K., Chu B., Alix S., Youle R.J., LaMarche A., Maroney A.C., and Johnson Jr. E.M. JNK-mediated BIM phosphorylation potentiates BAX-dependent apoptosis. Neuron. 38 (2003) 899-914
16. Yashar B.M., Kelley C., Yee K., Errede B., and Zon L.I. Novel members of the mitogen-activated protein kinase activator family in Xenopus laevis. Mol. Cell. Biol. 13 (1993) 5738-5748
17. Sanchez I., Hughes R.T., Mayer B.J., Yee K., Woodgett J.R., Avruch J., Kyriakis J.M., and Zon L.I. Role of SAPK/ERK kinase-1 in the stress-activated pathway regulating transcription factor c-jun. Nature 372 (1994) 794-800
18. Dérijard B., Raingeaud J., Barrett T., Wu I.H., Han J., Ulevitch R.J., and Davis R.J. Independent Human MAP kinase signal transduction pathways defined by MEK and MKK isoforms. Science 267 (1995) 682-685
19. Lin A., Minden A., Martinetto H., Claret F.-X., Lange-Carter C., Mercurio F., Johnson G.L., and Karin M. Identification of a dual specificity kinase that activates the Jun kinases and p38-Mpk2. Science 268 (1995) 286-290
20. Moriguchi T., Kawasaki H., Matsuda S., Gotoh Y., and Nishida E. Evidence for multiple activators for stress-activated protein kinases/c-Jun amino-terminal kinases. J. Biol. Chem. 270 (1995) 12969-12972
21. Meier R., Rouse J., Cuenda A., Nebreda A.R., and Cohen P. Cellular stresses and cytokines activate multiple mitogen-activated protein kinase homologues in PC12 and KB cells. Eur. J. Biochem. 236 (1996) 796-805
22. Nishina H., Fischer K.D., Radvanyi L., Shahinian A., Hakem R., Rubie E.A., Bernstein A., Mak T.W., Woodgett J.R., and Penninger J.M. Stress-signaling kinase Sek1 protects thymocytes from apoptosis mediated by CD95 and CD3. Nature 385 (1997) 350-353
23. 2-terminal kinase activation, and defects in AP-1 transcriptional activity. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 3004-3009
24. Ganiatsas S., Kwee L., Fujiwara Y., Perkins A., Ikeda T., Labow M.A., and Zon L.I. SEK1 deficiency reveals mitogen-activated-protein kinase cascade crossregulation and leads to abnormal hepatogenesis. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 6881-6886
25. Tournier C., Whitmarsh A., Cavanagh J., Barrett T., and Davis R.J. Mitogen-activated protein kinase kinase 7 is an activator of the c-Jun NH2-terminal kinase. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 7337-7342
26. Lu X., Nemoto S., and Lin A. Identification of c-Jun NH2-terminal protein kinase (JNK)-activating kinase 2 as an activator of JNK but not p38. J. Biol. Chem. 272 (1997) 24751-24754
27. Holland P.M., Suzanne M., Campbell J.S., Noselli S., and Cooper J.A. MKK7 is a stress-activated mitogen-activated protein kinase kinase functionally related to hemipterous. J. Biol. Chem. 272 (1997) 24994-24998
28. Yao Z., Diener K., Wang X.S., Zukowski M., Matsumoto G., Zhou G., Mo R., Sasaki T., Nishina H., Hui C.C., Tan T.H., Woodgett J.P., and Penninger J.M. Activation of stress-activated protein kinases/c-Jun N-terminal protein kinases (SAPKs/JNKs) by a novel mitogen-activated protein kinase kinase (MKK7). J. Biol. Chem. 272 (1997) 32378-32383
29. Wu Z., Wu J., Jacinto E., and Karin M. Molecular cloning and characterization of human JNKK2, a novel Jun NH2-terminal kinase specific kinase. Mol. Cell. Biol. 17 (1997) 7407-7416
30. Lawler S., Cuenda A., Goedert M., and Cohen P. SKK4, a novel activator of stress-activated protein kinase-1 (SAPK1/JNK). FEBS Lett. 414 (1997) 153-158
31. 2-terminal kinase kinases. Mol. Cell. Biol. 19 (1999) 1569-1581
32. Ho D.T., Bardwell A.J., Grewal S., Iverson C., and Bardwell L. Interacting JNK-docking sites in MKK7 promote binding and activation of JNK mitogen-activated protein kinases. J. Biol. Chem. 281 (2006) 13169-13179
33. Ho D.T., Bardwell A.J., Abdollahi M., and Bardwell L. A docking site in MKK4 mediates high affinity binding to JNK MAPKs and competes with similar docking sites in JNK substrates. J. Biol. Chem. 278 (2003) 32662-32672
34. Lee J.-K., Hwang W.-S., Lee Y.-D., and Han P.-L. Dynamic expression of SEK1 suggests multiple roles of the gene during embryogenesis and in adult brain of mice. Mol. Brain Res. 66 (1999) 133-140
35. Carboni L., Tacconi S., Carletti R., Bettini E., and Ferraguti F. Localization of the messenger RNA for the c-Jun NH2-terminal kinase kinase in the adult and developing rat brain: an in situ hybridization study. Neuroscience 80 (1997) 147-160
36. Nishina H., Vaz C., Billia P., Nghiem M., Sasaki T., De laPompa J.L., Furlonger K., Paige C., Hui C.-C., Fischer K.-D., Kishimoto H., Iwatsubo T., Katada T., Woodgett J.R., and Penninger J.M. Defective liver formation and liver cell apoptosis in mice lacking the stress signaling kinase SEK1/MKK4. Development 126 (1999) 505-516
37. Coffey E.T., Hongisto V., Dickens M., Davis R.J., and Courtney M.J. Dual roles for c-Jun N-terminal kinase in developmental and stress responses in cerebellar granule neurons. J. Neurosci. 20 (2000) 7602-7613
38. Rosso S.B., Sussman D., Wynshaw-Boris A., and Salinas P.C. Wnt signaling through Dishevelled, Rac and JNK regulates dendritic development. Nat. Neurosci. 8 (2005) 34-42
39. Hanks S.K., Quinn A.N., and Hunter T. The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. Science 241 (1988) 42-52
40. Brancho D., Tanaka N., Jaeschke A., Ventura J.J., Kelkar N., Tanaka Y., Kyuuma M., Takeshita T., Flavell R.A., and Davis R.J. Mechanism of p38 MAP kinase activation in vivo. Genes Dev. 17 (2003) 1969-1978
41. Lawler S., Fleming Y., Goedert M., and Cohen P. Synergistic activation of SAPK1/JNK1 by two MAP kinase kinases in vitro. Curr. Biol. 8 (1998) 1387-1390
42. Lisnock J.-M., Griffin P., Calaycay J., Frantz B., Parsons J., O'Keefe S.J., and LoGrasso P. Activation of JNK3α1 requires both MKK4 and MKK7: kinetic characterization of in vitro phosphorylation JNK3α1. Biochemistry 39 (2000) 3141-3148
43. Fleming Y., Armstrong C.G., Morrice N., Paterson A., Goedert M., and Cohen P. Synergistic activation of stress-activated protein kinase 1/c-Jun N-terminal kinase (SAPK1/JNK) isoforms by mitogen-activated protein kinase kinase 4 (MKK4) and MKK7. Biochem. J. 352 (2000) 145-154
44. Tournier C., Dong C., Turner T.K., Jones S.N., Flavell R.A., and Davis R.J. MKK7 is an essential component of the JNK signal transduction pathway activated by proinflammatory cytokines. Genes Dev. 15 (2001) 1419-1426
45. Wada T., Nakagawa K., Watanabe T., Nishitai G., Seo J., Kishimoto H., Kitagawa D., Sasaki T., Penninger J.M., Nishina H., and Katada T. Impaired synergistic activation of stress-activated protein kinase SAPK/JNK in mouse embryonic stem cells lacking SEK1/MKK4. J. Biol. Chem. 276 (2001) 30892-30897
46. Moriguchi T., Toyoshima F., Masuyama N., Hanafusa H., Gotoh Y., and Nishida E. A novel SAPK/JNK kinase, MKK7, stimulated by TNFα and cellular stresses. EMBO J. 16 (1997) 7045-7053
47. Finch A., Holland P., Cooper J., Saklatvala J., and Kracht M. Selective activation of JNK/SAPK by interleukin-1 in rabbit liver is mediated by MKK7. FEBS Lett. 418 (1997) 144-148
48. Kishimoto H., Nakagawa K., Watanabe T., Kitagawa D., Momose H., Seo J., Nishitai G., Shimizu N., Ohata S., Tanemura S., Asaka S., Goto T., Fukushi H., Yoshida H., Suzuki A., Sasaki T., Wada T., Penninger J.M., Nishina H., and Katada T. Different properties of SEK1 and MKK7 in dual phosphorylation of stress-induced activated protein kinase SAPK/JNK in embryonic stem cells. J. Biol. Chem. 278 (2003) 16595-16601
49. Takekawa M., Tatebayashi K., and Saito H. Conserved docking site is essential for activation of mammalian MAP kinase kinases by specific MAP kinase kinase kinases. Mol. Cell 18 (2005) 295-306
50. Xia Y., Wu Z., Su B., Murray B., and Karin M. JNKK1 organizes a MAP kinase module through specific and sequential interactions with upstream and downstream components mediated by its amino-terminal extension. Genes Dev. 12 (1998) 3369-3381
51. Cheng J., Yang J., Xia Y., Karin M., and Su B. Synergistic interaction of MEK kinase 2, c-Jun N-terminal kinase (JNK) kinase 2, and JNK1 results in efficient and specific JNK1 activation. Mol. Cell. Biol. 20 (2000) 2334-2342
52. Whitmarsh A.J. The JIP family of MAP kinase scaffold proteins. Biochem. Soc. Trans. 34 (2006) 828-832
53. Xu Z., Kukekov N.V., and Greene L.A. POSH acts as a scaffold for a multiprotein complex that mediates JNK activation in apoptosis. EMBO J. 22 (2003) 252-261
54. Kim G.H., Park E., and Han J.K. The assembly of POSH-JNK regulates Xenopus anterior neural development. Dev. Biol. 286 (2005) 256-269
55. Tsuda M., Langmann C., Harden N., and Aigaki T. The RING-finger scaffold protein plenty of SH3s targets TAK1 to control immunity signalling in Drosophila. EMBO Rep. 6 (2005) 1082-1087
56. Dong C., Yang D.D., Tournier C., Whitmarsh A.J., Xu J., Davis R.J., and Flavell R.A. JNK is required for effector T-cell function but not for T-cell activation. Nature 405 (2000) 91-94
57. Wada T., Joza N., Cheng H.Y.M., Sasaki T., Kozieradzki I., Bachmaier K., Katada T., Schreiber M., Wagner E.F., Nishina H., and Penninger J.M. MKK7 couples stress signalling to G2/M cell-cycle progression and cellular senescence. Nat. Cell. Biol. 6 (2004) 215-226
58. Watanabe T., Nakagawa K., Ohata S., Kitagawa D., Nishitai G., Seo J., Tanemura S., Shimizu N., Kishimoto H., Wada T., Aoki J., Arai H., Iwatsubo T., Mochita M., Watanabe T., Satake M., Ito Y., Matsuyama T., Mak T.W., Penninger J.M., Nishina H., and Katada T. SEK1/MKK4-mediated SAPK/JNK signaling participates in embryonic hepatoblast proliferation via a pathway different from NF-kappaB-induced anti-apoptosis. Dev. Biol. 250 (2002) 332-347
59. Nishina H., Bachmann M., Oliveiria-dos-Santos A.J., Kozieradzki I., Fischer K.D., Odermatt B., Wakeham A., Shahinian A., Takimoto H., Bernstein A., Mak T.W., Woodgett J.R., Ohashi P.S., and Penninger J.M. Impaired CD28-mediated interleukin 2 production and proliferation in stress kinase SAPK/ERK1 kinase (SEK1)/mitogen-activated protein kinase kinase 4 (MKK4)-deficient T lymphocytes. J. Exp. Med. 186 (1997) 941-953
60. Nishina H., Radvanyi L., Raju K., Sasaki T., Kozieradzki I., and Penninger J.M. Impaired TCR-mediated apoptosis and Bcl-XL expression in T cells lacking the stress kinase activator SEK1/MKK4. J. Immunol. 161 (1998) 3416-3420
61. Swat W., Fujikawa K., Ganiatsas S., Yang D., Xavier R.J., Harris N.L., Davidson L., Ferrini R., Davis R.J., Labow M.A., Flavell R.A., Zon L.I., and Alt F.W. SEK1/MKK4 is required for maintenance of a normal peripheral lymphoid compartment but not for lymphocyte development. Immunity 8 (1998) 625-634
62. Sasaki T., Wada T., Kishimoto H., Irie-Sasaki J., Matsumoto G., Goto T., Yao Z., Wakeham A., Mak T.W., Suzuki A., Cho S.K., Zuniga-Pflucker J.C., Oliveira-dos-Santos A.J., Katada T., Nishina H., and Penninger J.M. The stress kinase mitogen-activated protein kinase kinase (MKK7) is a negative regulator of antigen receptor and growth factor receptor-induced proliferation in hematopoietic cells. J. Exp. Med. 194 (2001) 757-768
63. Choukroun G., Hajjar R., Fry S., del Monte F., Haq S., Guerrero J.L., Picard M., Rosenzweig A., and Force T. Regulation of cardiac hypertrophy in vivo by the stress-activated protein kinases/c-JunNH(2)-terminalkinases. J Clin. Invest. 104 (1999) 391-398
64. Minamino T., Yujiri T., Terada N., Taffet G.E., Michael L.H., Johnson G.L., and Schneider M.D. MEKK1 is essential for cardiac hypertrophy and dysfunction induced by Gq. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 3866-3871
65. Sadoshima J., Montagne O., Wang Q., Yang G., Warden J., Liu J., Takagi G., Karoor V., Hong C., Johnson G.L., Vatner D.E., and Vatner S.F. The MEKK1-JNK pathway plays a protective role in pressure overload but does not mediate cardiac hypertrophy. J. Clin. Invest. 110 (2002) 271-279
66. Petrich B.G., Eloff B.C., Lerner D.L., Kovacs A., Saffitz J.E., Rosenbaum D.S., and Wang Y. Targeted activation of c-Jun N-terminal kinase in vivo induces restrictive cardiomyopathy and conduction defects. J. Biol. Chem. 279 (2004) 15330-15338
67. Mitchell S., Ota A., Foster W., Zhang B., Fang Z., Patel S., Nelson S.F., Horvath S., and Wang Y. Distinct gene expression profiles in adult mouse heart following targeted MAP kinase activation. Physiol. Genomics 25 (2006) 50-59
68. Teng D.H.-F., Perry III W.L., Hogan J.K., Baumgard M., Bell R., Berry S., Davis T., Frank D., Frye C., Hattier T., Hu R., Jammulapati S., Janecki T., Leavitt A., Mitchell J.T., Pero R., Sexton D., Schroeder M., Su P.H., Swedlund B., Kyriakis J.M., Avruch J., Bartel P., Wong A.K.C., Oliphant A., Thomas A., Skolnick M.H., and Tavtigian S.V. Human mitogen-activated protein kinase kinase 4 as a candidate tumor suppressor. Cancer Res. 57 (1997) 4177-4182
69. Su G.H., Hilgers W., Shekher M.C., Tang D.J., Yeo C.J., Hruban R.H., and Kern S.E. Alterations in pancreatic, biliary, and breast carcinomas support MKK4 as a genetically targeted tumor suppressor gene. Cancer Res. 58 (1998) 2339-2342
70. Kim H.L., Vander Griend D.J., Yang X., Benson D.A., Dubauskas Z., Yoshida B.A., Chekmareva M.A., Ichikawa Y., Sokoloff M.H., Zhan P., Karrison T., Lin A., Stadler W.M., Ichikawa T., Rubin M.A., and Rinker-Schaeffer C.W. Mitogen-activated protein kinase kinase 4 metastasis suppressor gene expression is inversely related to histological pattern in advancing human prostatic cancers. Cancer Res. 61 (2001) 2833-2837
71. Yamada S.D., Hickson J.A., Hrobowski Y., Vander Griend D.J., Benson D., Montag A., Karrison T., Huo D., Rutgers J., Adams S., and Rinker-Schaeffer C.W. Mitogen-activated protein kinase kinase 4 (MKK4) acts as a metastasis suppressor gene in human ovarian carcinoma. Cancer Res. 62 (2002) 6717-6723
72. Yoshida B.A., Dubauskas Z., Chekmareva M.A., Christiano T.R., Stadler W.M., and Rinker-Schaeffer C.W. Mitogen-activated protein kinase kinase 4/stress-activated protein/Erk kinase 1 (MKK4/SEK1), a prostate cancer metastasis suppressor gene encoded by human chromosome 17. Cancer Res. 59 (1999) 5483-5487
73. 2-terminal kinase kinases JNKK1/MKK4 and MKK7. Cancer Res. 65 (2005) 10984-10991
74. Hickson J.A., Huo D., Vander Griend D.J., Lin A., Rinker-Schaeffer C.W., and Yamada S.D. The p38 kinases MKK4 and MKK6 suppress metastatic colonization in human ovarian carcinoma. Cancer Res. 66 (2006) 2264-2270
75. Wang L., Pan Y., and Dai J.L. Evidence of MKK4 pro-oncogenic activity in breast and pancreatic tumors. Oncogene 23 (2004) 5978-5985
76. Cunningham S.C., Gallmeier E., Hucl T., Dezentje D.A., Calhoun E.S., Falco G., Abdelmohsen K., Gorospe M., and Kern S.E. Targeted deletion of MKK4 in cancer cells: a detrimental phenotype manifests as decreased experimental metastasis and suggests a counterweight to the evolution of tumor-suppressor loss. Cancer Res. 66 (2006) 5560-5564
77. 2-terminal kinase in oncogenic ras-induced morphologic transformation of human lung carcinoma cells. Cancer Res. 60 (2000) 400-408
78. Hess P., Pihan G., Sawyers C.L., Flavell R.A., and Davis R.J. Survival signaling mediated by c-Jun NH(2)-terminal kinase in transformed B lymphoblasts. Nat. Genet. 32 (2002) 201-205
79. Kennedy N.J., Sluss H.K., Jones S.N., Bar-Sagi D., Flavell R.A., and Davis R.J. Suppression of Ras-stimulated transformation by the JNK signal transduction pathway. Genes Dev. 17 (2003) 629-637
80. Hu M.C., Wang Y.P., Mikhail A., Qiu W.R., and Tan T.-H. Murine p38-delta mitogen-activated protein kinase, a developmentally regulated protein kinase that is activated by stress and proinflammatory cytokines. J. Biol. Chem. 274 (1999) 7095-7102